Close

Valeant Pharma (VRX) Receives Subpoena from California Department of Insurance

Go back to Valeant Pharma (VRX) Receives Subpoena from California Department of Insurance

Complete Donald Trump Stock Impact Guide

November 9, 2016 12:03 PM EST

Donald Trump's victory not only shocked the world but shocked the market. Below are all the sectors and stocks being impacted by his victory:

Biotech (Positive): Trump is viewed as less onerous than Clinton on drug pricing.

Gilead Sciences (NASDAQ: GILD) +4.5%Celgene (NASDAQ: CELG) +8.5%XBI (NYSE: XBI) is up 7%IBB (NYSE: IBB) is up 6.6%Alexion Pharmaceuticals (NASDAQ: ALXN)... More

Valeant Pharma (VRX) Shares See Early Bounce Higher

November 9, 2016 8:56 AM EST

Valeant Pharma (NYSE: VRX) shares are ticking higher early following a 22 percent drop on Monday amid weak Q3 results and cut outlook. The stock is up well over 2 percent ahead of the opening bell, going against broader market pressure.

... More